VIM and hepatocellular carcinoma: Immunohistochemical staining showed that HCC patients with low TXNDC12 expression showed higher E-cadherin and lower Vimentin expression levels, as well as lower ZEB1 expression levels, than HCC patients with high TXNDC12 expression (Fig. 3h, Supplementary Fig. 3a–c).